Novo Nordisk gets FDA expanded approval for hemophilia treatment

13 hours ago 1

Novo Nordisk (NVO) said it has received expanded approval from the FDA for Alhemo injection, as a treatment to help prevent or lessen bleeding episodes in both adult and pediatric patients aged 12 and older who have hemophilia A or

Recommended For You